Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,160,409
  • Shares Outstanding, K 32,706
  • Annual Sales, $ 566,770 K
  • Annual Income, $ 48,160 K
  • 60-Month Beta 1.03
  • Price/Sales 2.07
  • Price/Cash Flow 3.23
  • Price/Book 5.80
Trade COLL with:

Options Overview Details

View History
  • Implied Volatility 68.58% ( +2.32%)
  • Historical Volatility 32.68%
  • IV Percentile 95%
  • IV Rank 75.78%
  • IV High 88.09% on 09/21/23
  • IV Low 7.53% on 06/14/23
  • Put/Call Vol Ratio 2.00
  • Today's Volume 3
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 1,035
  • Open Int (30-Day) 1,103

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 1.37
  • Number of Estimates 4
  • High Estimate 1.45
  • Low Estimate 1.25
  • Prior Year 1.18
  • Growth Rate Est. (year over year) +16.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.24 +3.15%
on 04/19/24
40.95 -13.75%
on 03/28/24
-4.84 (-12.05%)
since 03/25/24
3-Month
31.34 +12.70%
on 02/21/24
40.95 -13.75%
on 03/28/24
+1.83 (+5.46%)
since 01/25/24
52-Week
20.83 +69.56%
on 07/06/23
40.95 -13.75%
on 03/28/24
+12.54 (+55.05%)
since 04/25/23

Most Recent Stories

More News
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 35.71 (+0.65%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 35.71 (+0.65%)
A Little Known Strategy Indicates These Three Companies Could Explode!

In this article, we look at price action strategies and uncover three companies with the potential for a breakout.

VSEC : 76.88 (-2.20%)
BAH : 145.09 (+0.48%)
COLL : 35.71 (+0.65%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 35.71 (+0.65%)
Collegium Pharmaceutical (COLL) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with...

COLL : 35.71 (+0.65%)
Collegium Pharmaceutical (COLL) Q1 Earnings Meet Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

COLL : 35.71 (+0.65%)
XBIO : 3.77 (-9.38%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 35.71 (+0.65%)
Pacira (PCRX) Lags Q1 Earnings Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -11.67% and 2.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PCRX : 25.61 (-1.12%)
COLL : 35.71 (+0.65%)
COLL vs. ZTS: Which Stock Should Value Investors Buy Now?

COLL vs. ZTS: Which Stock Is the Better Value Option?

COLL : 35.71 (+0.65%)
ZTS : 151.17 (+0.19%)
Pacira's (PCRX) Q4 Earnings Match Estimates, Revenues Fall

Pacira BioSciences (PCRX) reports mixed fourth-quarter financial results, where earnings match estimates, but revenues miss the mark.

PCRX : 25.61 (-1.12%)
CPRX : 14.78 (-2.25%)
COLL : 35.71 (+0.65%)
RCEL : 8.28 (-3.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 36.58
2nd Resistance Point 36.30
1st Resistance Point 35.89
Last Price 35.71
1st Support Level 35.20
2nd Support Level 34.92
3rd Support Level 34.51

See More

52-Week High 40.95
Last Price 35.71
Fibonacci 61.8% 33.26
Fibonacci 50% 30.89
Fibonacci 38.2% 28.52
52-Week Low 20.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar